Doxorubicin (liposomal) 50mg powder and solvent for suspension for infusion vials
| ID | 9526811000001106 |
|---|---|
| Therapeutic Moiety | Doxorubicin (liposomal) |
| Name | Doxorubicin (liposomal) 50mg powder and solvent for suspension for infusion vials |
| Abbreviated name | Doxorubicin (liposomal) 50mg inf vials |
| Preferred name basis | rINN - Recommended International Non-proprietary |
| Date of name applicability | 12 Feb 2010 |
| Previous name | Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Non-availability indicator | Actual Products not Available |
| Non availability status date | 8 Oct 2019 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Ingredients | Doxorubicin hydrochloride liposomal pegylated |
| Form & Route | suspensioninfusion.intravenous |
| Drug formulations | Powder and solvent for suspension for infusion |
| Drug route | Intravenous |
| Control drug | No Controlled Drug Status |